Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 2:12:329.
doi: 10.3389/fncel.2018.00329. eCollection 2018.

Role of Microglia TLRs in Neurodegeneration

Affiliations

Role of Microglia TLRs in Neurodegeneration

Bernd L Fiebich et al. Front Cell Neurosci. .

Abstract

Toll-like receptors (TLRs) are a group of receptors widely distributed in the organism. In the central nervous system, they are expressed in neurons, astrocytes and microglia. Although their involvement in immunity is notorious, different articles have demonstrated their roles in physiological and pathological conditions, including neurodegeneration. There is increasing evidence of an involvement of TLRs, especially TLR2, 4 and 9 in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). In this sense, their expression in microglia might modulate the activity of these cells, which in turn, lead to protective or deleterious effects over neurons and other cells. Therefore, TLRs might mediate the link between inflammation and neurodegenerative diseases. However, further studies have to be performed to elucidate the role of the other TLRs in these diseases and to further prove and confirm the pathophysiological role of all TLRs in neurodegeneration. In this article, we revise and summarize the current knowledge regarding the role of TLRs in neurodegeneration with the focus on the possible functions of these receptors in microglia.

Keywords: Alzheimer’s disease; Parkinson’s disease; inflammatory mediators; microglia; neurodegenerative diseases; neuroinflammation; toll-like receptors (TLRs).

PubMed Disclaimer

Similar articles

Cited by

References

    1. Balducci C., Frasca A., Zotti M., La Vitola P., Mhillaj E., Grigoli E., et al. . (2017). Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer’s disease. Brain Behav. Immun. 60, 188–197. 10.1016/j.bbi.2016.10.012 - DOI - PubMed
    1. Béraud D., Maguire-Zeiss K. A. (2012). Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson’s disease. Parkinsonism Relat. Disord. 18, S17–S20. 10.1016/S1353-8020(11)70008-6 - DOI - PMC - PubMed
    1. Béraud D., Twomey M., Bloom B., Mittereder A., Ton V., Neitzke K., et al. . (2011). α-synuclein alters toll-like receptor expression. Front. Neurosci. 5:80. 10.3389/fnins.2011.00080 - DOI - PMC - PubMed
    1. Boche D., Perry V. H., Nicoll J. A. R. (2013). Review: activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 39, 3–18. 10.1111/nan.12011 - DOI - PubMed
    1. Bowman C. C., Rasley A., Tranguch S. L., Marriott I. (2003). Cultured astrocytes express toll-like receptors for bacterial products. Glia 43, 281–291. 10.1002/glia.10256 - DOI - PubMed